Takeda and Shire Have a $60 Billion Drug Problem

Bookmark
(Bloomberg Opinion) -- The cleverest corporate strategies can come unstuck when they meet reality. That may include the ambitious plan hatched by Japan's Takeda Pharmaceuticals Co. to buy the Briti...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.